Auvelity (Dextromethorphan/Bupropion)

Approved for AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.. Dextromethorphan is an uncompetitive antagonist of the NMDA receptor (an ionotropic glutamate receptor) and a sigma-1 receptor agonist. The mechanism of dextromethorphan in the treatment of MDD is… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…

Loading full data from Know Your Drugs Institute…